SMAD3在声带损伤中的表达及对纤维增生的调控
该研究在兔单侧声带损伤模型中定量SMAD3和SMAD7 mRNA在损伤后多个时间点的表达,并在体外用人声带成纤维细胞系分析TGF-β1刺激±SMAD3敲低后的多基因表达。结果显示损伤后SMAD3 mRNA在3天和7天显著上调,SMAD7在3、7、14天上调;体外SMAD3敲低在6和24小时降低多个促纤维化、TGF-β信号及细胞外基质代谢基因的表达。
要点
- 兔声带损伤后SMAD3 mRNA在3天和7天较对照显著上调(均P<0.001)。
- SMAD7 mRNA在损伤后3、7、14天分别上调(P=0.02、P<0.001、P<0.001)。
- 体外SMAD3敲低在TGF-β1刺激后6和24小时降低多个促纤维化及TGF-β信号基因表达。
核心结论
- 数据支持SMAD3是TGF-β介导纤维化的潜在主调控因子。
- SMAD3转录在损伤后7天达峰。
- 多基因分析提示SMAD3敲低的治疗有效性可能与调控纤维增生下游介质及改变TGF-β信号有关。
研究设计与样本
- 体内与体外研究。
- 体内采用兔单侧声带损伤模型,定量损伤后1小时及1、3、7、14、30、60、90天的SMAD3和SMAD7 mRNA表达。
- 体外采用永生化人声带成纤维细胞系,在TGF-β1刺激±SMAD3敲低后多时间点行多基因分析。
主要发现
- 声带损伤后SMAD3 mRNA表达增加,3天和7天较对照显著上调(均P<0.001)。
- SMAD7 mRNA在损伤后3、7、14天也上调(分别为P=0.02、P<0.001、P<0.001)。
- 体外TGF-β1刺激后6和24小时,SMAD3敲低降低多个促纤维化、TGF-β信号及细胞外基质代谢基因的表达。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Recent reports highlight the efficacy of small interfering RNA (siRNA) targeting SMAD3 to regulate transforming growth factor β (TGF-β)-mediated fibroplasia in vocal fold fibroblasts. The current study sought to investigate SMAD3 expression during wound healing in vivo and quantify the downstream transcriptional events associated with SMAD3 knockdown in vitro. STUDY DESIGN: In vivo and in vitro. METHODS: Unilateral vocal fold injury was created in a rabbit model. SMAD3 and SMAD7 mRNA expression was quantified at 1 hour and 1, 3, 7, 14, 30, 60, and 90 days following injury. In vitro, multi-gene analysis technology was employed in our immortalized human vocal-fold fibroblast cell line following TGF-β1 stimulation ± SMAD3 knockdown across time points. RESULTS: SMAD3 mRNA expression increased following injury; upregulation was significant at 3 and 7 days compared to control (both P < 0.001). SMAD7 mRNA was also upregulated at 3, 7, and 14 days (P = 0.02, P < 0.001, and P < 0.001, respectively). In vitro, SMAD3 knockdown reduced the expression of multiple profibrotic, TGF-β signaling, and extracellular matrix metabolism genes at 6 and 24 hours following TGF-β1 stimulation. CONCLUSION: Cumulatively, these data support SMAD3 as a potential master regulator of TGF-β-mediated fibrosis. SMAD3 transcription peaked 7 days following injury. Multi-gene analysis indicated that the therapeutic effectiveness of SMAD3 knockdown may be related to regulation of downstream mediators of fibroplasia and altered TGF-β signaling. LEVEL OF EVIDENCE: NA. Laryngoscope, 127:E308-E316, 2017.
引用
- Hiwatashi N, Benedict PA, Dion GR, et al. SMAD3 expression and regulation of fibroplasia in vocal fold injury. Laryngoscope. 2017. PMID: 28543554. doi:10.1002/lary.26648
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。